ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

NY Federal Court Rules Against Myriad, Finding Patents On Genes Unlawful.

April 2, 2010

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988

Double Trouble For NIH: Democrats Offer Small Increases, Bush May Veto The Bill.

July 6, 2007

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Harold Varmus Addresses the NCI Board of Scientific Advisors

March 8, 2013

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010